SPRC SciSparc Ltd
Price Chart
Executive Summary
SciSparc's majority-owned subsidiary NeuroThera closed its acquisition of a ~54% interest in CliniQuantum for ~CAD$9.5M in stock, with potential earn-out payments up to US$2.5M. This is a small, non-cash deal for a micro-cap biotech with no immediate revenue impact, and the historical calibration shows prior neutral reports on SPRC have underperformed significantly at T+20.
Key Financial Metrics
Actionable Insight
The deal adds a speculative quantum analytics angle but no near-term revenue. Given SPRC's micro-cap status and poor historical T+20 performance, traders should treat this as a non-event for the parent stock. Monitor for any future CliniQuantum milestones that could trigger earn-outs.
Key Facts
- NeuroThera acquired ~54% of CliniQuantum for ~CAD$9.5M in stock (56.6M shares).
- Earn-out payments up to US$2.5M contingent on patent filings and fundraising milestones.
- CliniQuantum holds a license for quantum simulation technology applied to clinical trial data.
- SciSparc's market cap is ~$5M; the deal is small relative to the parent company's size.
- Historical SPRC reports show a 0% win rate at T+20 with an average alpha of -26.39%.
Financial Impact
Consideration of ~CAD$9.5M in NeuroThera shares; earn-out up to US$2.5M over 3 years. No cash outlay.
Risk Factors
- Dilution from NeuroThera share issuance to CliniQuantum sellers.
- Earn-out milestones may never be achieved; no guaranteed return.
- SPRC's low liquidity and small market cap amplify volatility on any news.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3306664 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
2d ago
|
6-K
| $11.54 $11.44 | ▼ −0.87% | ▲ +1.73% | $11.44 (−0.87%) |
|
Jun 4, 2026
2d ago
|
Press Release
| $11.54 $11.44 | ▼ −0.87% | ▲ +1.73% | $11.44 (−0.87%) |
|
May 29, 2026
8d ago
|
6-K
| $9.81 $10.59 | ▲ +7.95% | ▲ +7.68% | $11.44 (+16.62%) |
|
May 28, 2026
9d ago
|
Press Release
| $10.55 $9.81 | ▼ −7.01% | ▼ −7.26% | $11.44 (+8.44%) |
|
Mar 16, 2026
11w ago
|
Press Release
| $4.32 $4.62 | ▲ +6.94% | ▲ +6.67% | $11.44 (+164.81%) |
|
Mar 12, 2026
12w ago
|
Press Release
| $4.73 $4.36 | ▼ −7.82% | ▼ −7.22% | $11.44 (+141.86%) |
|
Mar 10, 2026
12w ago
|
Press Release
| $4.02 $3.85 | ▼ −4.23% | ▼ −4.12% | $11.44 (+184.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access